Atea Pharmaceuticals Narrows Third-Quarter Loss and Secures Up to $200 Million Credit Facility
AVIR Atea Pharmaceuticals Inc
$4.20 -4.76%
View chart & analysis → - 1Atea Pharmaceuticals Inc recorded a third-quarter loss of $0.40 per share.
- 2This exceeded the third-quarter consensus estimate of -$0.51 by 21.6%.
- 3The company secured a credit facility of up to $200 million from Hercules Capital.
So what's the key point?
Atea Pharmaceuticals Inc lost less money than expected. The loss was 21.6 percent smaller than what experts predicted, and the company also gained the right to borrow a large amount of money.
Source Earnings Whispers · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.